Saturday, November 15, 2014

Reversing the pathophysiology of metabolic syndrome

By Michael P. Ciell, RPH 

Metabolic Syndrome (aka Syndrome X, or MetSyn), with its four hallmark symptoms of obesity, hypertension, dyslipidemia, and hyperglycemia, is an increasing health risk for the U.S. population.
In March 2005, the National Institutes of Health and the New England Journal of Medicine published a paper stating that because of this epidemic, the current generation is projected to have a shorter life expectancy then the previous one — for the first time in recorded history. Since then, things have gotten worse.1

The crisis continues despite changes in the USDA food pyramid, the emergence of new pharmaceutical agents (especially for pre-diabetes and type II diabetes), the removal of soda vending machines from schools, and even first lady Michelle Obama’s crusade against obesity. MetSyn, with its comorbidities (cardiovascular disease, stroke, blindness, amputations, etc.), accounts for the majority of healthcare dollars being spent.

http://www.chiroeco.com/news/chiro-article.php?id=12175

No comments:

Post a Comment